Myosteatosis can Predict Unfavorable Outcomes in Advanced Hepatocellular Carcinoma Patients Treated With Hepatic Artery Infusion Chemotherapy and Anti-PD-1 Immunotherapy

AIM: To evaluate the feasibility of computed tomography (CT) - derived measurements of body composition parameters to predict the risk factor of non-objective response (non-OR) in patients with hepatocellular carcinoma (HCC) undergoing anti-PD-1 immunotherapy and hepatic artery infusion chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Xiaoping, Fu, Yan, Long, Qianyan, Zhao, Yazhuo, Li, Sai, Zhou, Chunhui, Lin, Huashan, Liu, Xiaolian, Liu, Chang, Chen, Changyong, Shi, Liangrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149214/
https://www.ncbi.nlm.nih.gov/pubmed/35651812
http://dx.doi.org/10.3389/fonc.2022.892192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149214/
https://www.ncbi.nlm.nih.gov/pubmed/35651812
http://dx.doi.org/10.3389/fonc.2022.892192

Ejemplares similares